seroquel Resources | BNET
On The Insider: Sexiest Magazine Covers of All Time

Resources

12 Resources for

seroquel

  • Subscribe to this listing via:
  • RSS
  • Email
FDA warns of Seroquel, Serzone errors
The FDA has warned healthcare professionals about prescribing errors involving AstraZeneca's Seroquel quetiapine fumarate and Bristol-Myers Squibb's Serzone nefazodone hydrochloride. The medication errors resulted from a similarity in names, overlapping strengths (100 mg and 200 mg), dosage form tablets, the dosing interval BID, as well as the fact that both...
Tags: FDA
Research articles 2002-08-01
FDA Approves AstraZeneca's Seroquel® for Maintenance Treatment in Bipolar Disorder
WILMINGTON, Del., May 14 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the U.S. Food and Drug Administration FDA has approved SEROQUELR quetiapine fumarate tablets for the maintenance treatment of patients with bipolar I disorder, as adjunct therapy to lithium or divalproex. SEROQUEL is approved by the FDA for the...
Tags: AstraZeneca Plc., FDA
Research articles 2008-05-14
FDA: Seroquel sales aid is misleading
THE FDA HAS asked AstraZeneca to halt distribution of a professional sales aid used to market its antipsychotic medication Seroquel.
Tags: FDA, sales
Research articles 2007-01-01
FDA Clears Zeneca's SEROQUEL for the Management of the Manifestations of Psychotic Disorders, Including Schizophrenia - r - quetiapine fumarate
WILMINGTON, Del.--BUSINESS WIRE--September 29, 1997--Zeneca Pharmaceuticals today announced that the Food and Drug Administration FDA has cleared for marketing SEROQUELr quetiapine fumarate tablets, an oral medication indicated for the management of the manifestations of psychotic disorders, including schizophrenia. SEROQUEL is a new "atypical" antipsychotic agent in a new chemical...
Tags: FDA
Research articles 1997-09-29
ASTRAZENECA.(new plant)(Brief Article)
ASTRAZENECA is investing $60 million in its manufacturing site at Macclesfield, northwest England, to meet growing demand for Seroquel ... ASTRAZENECA is investing $60 million in its manufacturing site at Macclesfield, northwest England, to meet growing demand for Seroquel quetiapine, its atypical antipsychotic...
Tags: AstraZeneca Plc.
Research articles 2001-01-22
AstraZeneca Submits sNDA for SEROQUEL XR™ for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
WILMINGTON, Del., May 8 /PRNewswire-FirstCall/ -- AstraZeneca today announced the submission of a supplemental New Drug Application sNDA to the U.S. Food and Drug Administration FDA for SEROQUEL XRTM quetiapine fumarate Extended-Release Tablets to seek approval for the treatment of generalized anxiety disorder GAD, including maintenance of antianxiety...
Tags: AstraZeneca Plc.
Research articles 2008-05-08
ASTRAZENECA (AZN).
AstraZeneca's tactic of growing profits by trimming costs and relying on its "five key products" continues to pay dividends. These products are stomach ulcer drug Nexium, psychiatric product Seroquel, cholesterol-lowering drug Crestor, asth AstraZeneca's tactic of growing profits by trimming costs and relying on its...
Tags: AstraZeneca Plc.
Research articles 2006-08-04
Seroquel PBS listed.(Clinical report)
Simone Roberts Simone Roberts
Tags: PBS
Research articles 2007-12-06
Astrazeneca's drug may cause memory loss.
AstraZeneca's psychiatric drug, Seroquel, may worsen the symptoms of Alzheimer's disease. Study data published in the British Medical Journal suggests memory function deterioration doubled in Alzheimer's patients taking the drug, which is approved to AstraZeneca's psychiatric drug, Seroquel, may worsen the symptoms of Alzheimer's disease....
Tags: Alzheimer's disease, AstraZeneca Plc.
Research articles 2005-02-25
AstraZeneca's Once-Daily SEROQUEL XR(TM) Extended-Release Tablets Approved in Netherlands for the Acute and Long Term Treatment of Schizophrenia.
LONDON, August 29 /PRNewswire/ -- LONDON, August 29 /PRNewswire/ --
Tags: AstraZeneca Plc.
Research articles 2007-08-29
Research & Markets: Only Eli Lilly's Symbyax and AstraZeneca's Seroquel have Received FDA Approval for Treatment of Bipolar Depression
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c53479) has announced the addition of the Decision Resources, Inc report: Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market? to their offering.
Tags: AstraZeneca Plc., Eli Lilly & Co.
Research articles 2007-04-05
AstraZeneca Q3 2007 Earnings Call Transcript
Question-and-Answer SessionOperator Ladies and gentlemen, the question-and-answer session will be conducted electronically. Operator Instructions Our first question will come from Ms. Alexandra Hauber with Bear Stearns. Please go ahead. Alexandra Hauber - Bear Stearns Yes, good afternoon. I have four questions please. David, could you speak a bit to...
Tags: AstraZeneca Plc.
Earnings calls 2007-11-01
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement